Pioglitazone versus glimepiride on coronary artery calcium progression in patients with type 2 diabetes mellitus: A secondary end point of the CHICAGO study

Arteriosclerosis, Thrombosis, and Vascular Biology

Volumn 30, Issue 9, 2010, Pages 1873-1876

  Davidson, Michael H ^a   Beam, Craig A ^b   Haffner, Steven ^c   Perez, Alfonso ^d   Dagostino, Ralph ^e   Mazzone, Theodore ^f  

^a UNIVERSITY OF CHICAGO   (United States)

^b UNIVERSITY OF SOUTH FLORIDA   (United States)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

^d TAKEDA PHARMACEUTICALS   (United States)

^e Boston University   (United States)

^f UNIVERSITY OF ILLINOIS AT CHICAGO   (United States)

Author keywords

atherosclerosis; coronary artery calcium; diabetes mellitus; insulin resistance; lipoproteins

Indexed keywords

APOLIPOPROTEIN B; CALCIUM; GLIMEPIRIDE; PIOGLITAZONE; 2,4 THIAZOLIDINEDIONE DERIVATIVE; ANTIDIABETIC AGENT; SULFONYLUREA DERIVATIVE;

ADULT; AGE; AGED; ARTERIAL WALL THICKNESS; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORONARY ARTERY; DIABETIC PATIENT; DISEASE COURSE; ELECTRON BEAM TOMOGRAPHY; ETHNICITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; CALCINOSIS; CAROTID ARTERY DISEASES; CHI SQUARE DISTRIBUTION; COMPARATIVE STUDY; COMPLICATION; COMPUTER ASSISTED TOMOGRAPHY; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; ECHOGRAPHY; MIDDLE AGED; RADIOGRAPHY; RISK ASSESSMENT; RISK FACTOR; TIME; TREATMENT OUTCOME;

AGED; CALCINOSIS; CAROTID ARTERY DISEASES; CHI-SQUARE DISTRIBUTION; CORONARY ARTERY DISEASE; DIABETES MELLITUS, TYPE 2; DISEASE PROGRESSION; FEMALE; HUMANS; HYPOGLYCEMIC AGENTS; MALE; MIDDLE AGED; RISK ASSESSMENT; RISK FACTORS; SULFONYLUREA COMPOUNDS; THIAZOLIDINEDIONES; TIME FACTORS; TOMOGRAPHY, X-RAY COMPUTED; TREATMENT OUTCOME;

EID: 77955984948     PISSN: 10795642     EISSN: None     Source Type: Journal    
DOI: 10.1161/ATVBAHA.110.207696     Document Type: Article

References (24)

1. Demer LL. Cholesterol in vascular and valvular calcification. Circulation. 2001;104:1881-1883.
2. Schurgin S, Rich S, Mazzone T. Increased prevalence of significant coronary artery calcification in patients with diabetes. Diabetes Care. 2001;24:335-338.
3. Guerci AD, Spadaro LA, Popma JJ, Goodman KJ, Brundage BH, Budoff M, Lerner G, Vizza RF. Relation of coronary calcium score by electron beam computed tomography to arteriographic findings in asymptomatic and symptomatic adults. Am J Cardiol. 1997;79:128-133.
4. Rumberger JA, Simons DB, Fitzpatrick LA, Sheedy PF, Schwartz RS. Coronary artery calcium area by electron-beam computed tomography and coronary atherosclerotic plaque area: a histopathologic correlative study. Circulation. 1995;92:2157-2162.
5. Olson JC, Edmundowicz D, Becker DJ, Kuller LH, Orchard TJ. Coronary calcium in adults with type 1 diabetes: a stronger correlate of clinical coronary artery disease in men than in women. Diabetes. 2000;49:1571-1578.
6. Mazzone T, Meyer PM, Feinstein SB, Davidson MH, Kondos GT, D'Agostino RB, Perez A, Provost JC, Haffner SM. Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial. JAMA. 2006;296:2572-2581.
7. Mazzone T, Meyer PM, Kondos GT, Davidson MH, Feinstein SB, D'Agostino RB, Perez A, Haffner SM. Relationship of traditional and non-traditional cardiovascular risk factors to coronary artery calcium in type 2 diabetes. Diabetes. 2007;56:849-855.
8. Sam S, Haffner S, Davidson MH, D'Agostino RB, Feinstein S, Kondos G, Perez A, Mazzone T. Relationship of abdominal visceral and subcutaneous adipose tissue to lipoprotein particle number and size in type 2 diabetes. Diabetes. 2008;57:2022-2027.
9. Sam S, Haffner S, Davidson MH, D'Agostino RB Sr, Feinstein S, Kondos G, Perez A, Mazzone T. Relation of abdominal fat depots to systemic markers of inflammation in type 2 diabetes. Diabetes Care. 2009;32:932-937.
10. Sam S, Haffner S, Davidson MH, D'Agostino RB Sr, Feinstein S, Kondos G, Perez A, Mazzone T. Hypertriglyceridemic waist phenotype predicts increased visceral fat in subjects with type 2 diabetes. Diabetes Care. 2009;32:1916-1920.
11. Davidson M, Meyer PM, Haffner S, Feinstein S, D'Agostino R Sr, Kondos GT, Perez A, Chen Z, Mazzone T. Increased high-density lipoprotein cholesterol predicts the pioglitazone-mediated reduction of carotid intima-media thickness progression in patients with type 2 diabetes mellitus. Circulation. 2008;117:2123-2130.
12. Holme I, Cater NB, Faergeman O, Kastelein JJ, Olsson AG, Tikkanen MJ, Larsen ML, Lindahl C, Pedersen TR. Lipoprotein predictors of cardiovascular events in statin-treated patients with coronary heart disease: insights from the Incremental Decrease In End-points Through Aggressive Lipid-lowering Trial (IDEAL). Ann Med. 2008;40:456-464.
13. Martin SS, Qasim AN, Mehta NN, Wolfe M, Terembula K, Schwartz S, Iqbal N, Schutta M, Bagheri R, Reilly MP. Apolipoprotein B but not LDL cholesterol is associated with coronary artery calcification in type 2 diabetic whites. Diabetes. 2009;58:1887-1892.
14. Kronmal RA, McClelland RL, Detrano R, Shea S, Lima JA, Cushman M, Bild DE, Burke GL. Risk factors for the progression of coronary artery calcification in asymptomatic subjects: results from the Multi-Ethnic Study of Atherosclerosis (MESA). Circulation. 2007;115:2722-2730.
15. McClelland RL, Chung H, Detrano R, Post W, Kronmal RA. Distribution of coronary artery calcium by race, gender, and age: results from the MultiEthnic Study of Atherosclerosis (MESA). Circulation. 2006;113:30-37.
16. Bild DE, Detrano R, Peterson D, Guerci A, Liu K, Shahar E, Ouyang P, Jackson S, Saad MF. Ethnic differences in coronary calcification: the MultiEthnic Study of Atherosclerosis (MESA). Circulation. 2005;111:1313-1320.
17. Budoff MJ, Nasir K, Mao S, Tseng PH, Chau A, Liu ST, Flores F, Blumenthal RS. Ethnic differences of the presence and severity of coronary atherosclerosis. Atherosclerosis. 2006;187:343-350.
18. Diez Roux AV, Detrano R, Jackson S, Jacobs DR Jr, Schreiner PJ, Shea S, Szklo M. Acculturation and socioeconomic position as predictors of coronary calcification in a multiethnic sample. Circulation. 2005;112:1557-1565.
19. Nissen SE, Nicholls SJ, Wolski K, Nesto R, Kupfer S, Perez A, Jure H, De Larochelliere R, Staniloae CS, Mavromatis K, Saw J, Hu B, Lincoff AM, Tuzcu EM. Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial. JAMA. 2008;299:1561-1573.
20. Dormandy JA, Charbonnel B, Eckland DJ, Erdmann E, Massi-Benedetti M, Moules IK, Skene AM, Tan MH, Lefebvre PJ, Murray GD, Standl E, Wilcox RG, Wilhelmsen L, Betteridge J, Birkeland K, Golay A, Heine RJ, Koranyi L, Laakso M, Mokan M, Norkus A, Pirags V, Podar T, Scheen A, Scherbaum W, Schernthaner G, Schmitz O, Skrha J, Smith U, Taton J. Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macro-Vascular Events): a randomised controlled trial. Lancet. 2005;366: 1279-1289.
21. Erdmann E, Dormandy JA, Charbonnel B, Massi-Benedetti M, Moules IK, Skene AM. The effect of pioglitazone on recurrent myocardial infarction in 2,445 patients with type 2 diabetes and previous myocardial infarction: results from the PROactive (PROactive 05) Study. J Am Coll Cardiol. 2007;49:1772-1780.
22. Folsom AR, Kronmal RA, Detrano RC, O'Leary DH, Bild DE, Bluemke DA, Budoff MJ, Liu K, Shea S, Szklo M, Tracy RP, Watson KE, Burke GL. Coronary artery calcification compared with carotid intima-media thickness in the prediction of cardiovascular disease incidence: the Multi-Ethnic Study of Atherosclerosis (MESA). Arch Intern Med. 2008;168:1333-1339.
23. McCullough PA, Chinnaiyan KM. Annual progression of coronary calcification in trials of preventive therapies: a systematic review. Arch Intern Med. 2009;169:2064-2070.
24. Brunzell JD, Davidson M, Furberg CD, Goldberg RB, Howard BV, Stein JH, Witztum JL. Lipoprotein management in patients with cardiometabolic risk: consensus conference report from the Am Diabetes Association and the Am College of Cardiology Foundation. J Am Coll Cardiol. 2008;51:1512-1524.